Cable Hill Partners, LLC Sangamo Therapeutics, Inc Transaction History

Cable Hill Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$8.75 - $13.03 $23,187 - $34,529	-2,650 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$7.72 - $12.81 $7,720 - $12,810	1,000 Added 60.61%	2,650 $25,000
Q4 2017 Feb 22, 2018	BUY	$11.6 - $17.35 $19,140 - $28,627	1,650	1,650 $29,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $360M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.